Search

everythinglearnresearchcommunity

for

Search:↓

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Hormones are crucial for regulating body functions and imbalances can lead to health issues.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Raising awareness about PCOS can improve women's quality of life.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Hormone therapy affects cancer risks in transgender individuals differently than in cisgender people, and more research is needed to understand these risks and improve cancer screening guidelines.

The method accurately measures 19 steroid hormones in human blood and urine using a small sample and is suitable for large-scale monitoring.

Women with excessive hair growth tend to have shorter index and ring fingers compared to others.

Women with early-onset baldness should be checked for early bone loss, but bone density doesn't change with baldness severity.

A transwoman developed a brain tumor after nine years of hormone therapy, suggesting a possible link between the treatment and tumor development.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Hormone therapy improves mental well-being in transgender individuals but requires ongoing health monitoring.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Women with Female Pattern Hair Loss may experience more stress, anxiety, and depression, and have lower levels of BDNF, which could predict the psychological impact.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Sebum production varies by individual and is influenced by age, gender, and hormones, affecting skin and hair health.

Sulforaphane may help with hair growth by breaking down a hormone that causes hair loss.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

Frontal fibrosing alopecia in Brazil mostly affects postmenopausal women, often linked with hypothyroidism and eyebrow hair loss.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

A woman with low thyroid function did not lose her hair during chemotherapy, possibly because her hair follicles were less affected by the treatment.

Menopause causes dry skin, wrinkles, and hair changes, with hormone therapy helping but not recommended just for these issues.